Monocyte Chemoattractant Protein-1 in Psoriatic Arthritis Patients

Heart Function in Rheumatoid Arthritis and Ankylosing Spondylitis Pre and Post-TNF Blocker

NCT01072058 ·Status: UNKNOWN ·Phase: PHASE4

PsA Secukinumab XCT Structural Progression Study

NCT03623867 ·Status: COMPLETED ·Phase: PHASE4

Tofacitinib for Reduction of Spinal Inflammation in Patients With Psoriatic ArthritiS PresenTing With Axial InvOlvement

NCT04062695 ·Status: UNKNOWN ·Phase: PHASE2

Lymphocyte and Cytokine Disturbances in Polymyalgia Rheumatica

NCT02888496 ·Status: COMPLETED

Study of the Functional Status Neutrophils in Rheumatoid Arthritis Patients to Identify New Biomarkers of Response to Anti-TNFalpha Therapy

NCT05802719 ·Status: RECRUITING ·Phase: NA

A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis

NCT01519791 ·Status: COMPLETED ·Phase: PHASE3

Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis

NCT01976364 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis

NCT07223138 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3

Tapering of Biologics in Inflammatory Arthritis Patients in Remission

NCT04429776 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

COVID-SErology in Rheumatoid Arthritis (COVID-19)

NCT04407559 ·Status: COMPLETED

Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Moderately to Severely Active Psoriatic Arthritis

NCT00646386 ·Status: COMPLETED ·Phase: PHASE2

An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants

NCT00760669 ·Status: COMPLETED

Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis

NCT01087788 ·Status: COMPLETED ·Phase: PHASE3

Multicenter Randomized Prospective Trial Comparing Methotrexate Alone or in Combination With Adalimumab in Early Arthritis

NCT00291915 ·Status: UNKNOWN ·Phase: PHASE4

Safety and Tolerability of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis

NCT01169844 ·Status: COMPLETED ·Phase: PHASE2

Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis

NCT04871919 ·Status: ACTIVE_NOT_RECRUITING

Vaccination Against SARS-Cov2 (COVID-19) in Chronic Inflammatory Rheumatism and Factors Determining Its Decision.

NCT04970550 ·Status: COMPLETED

Monoarticular Corticosteroid Injection Versus Systemic Administration in the Treatment of Rheumatoid Arthritis Patients

NCT00506896 ·Status: COMPLETED ·Phase: PHASE2

Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis

NCT04610476 ·Status: UNKNOWN ·Phase: PHASE3

Identification of Factors Associated With the Occurrence of Severe Forms of COVID-19 Infection in Patients With Inflammatory Rheumatism or Autoimmune Diseases

NCT05026892 ·Status: UNKNOWN

Biomarkers in Rheumatoid Arthritis Treated With Anti-interleukin-6 Therapy

NCT04281602 ·Status: UNKNOWN

Single Dose PG102 in Patients With Active Psoriatic Arthritis

NCT00787137 ·Status: TERMINATED ·Phase: PHASE1

Serum Anti-PCOLCE as Novel Diagnostic Biomarker in Rheumatoid Arthritis With Emphasis on Seronegative Patients.

NCT07129837 ·Status: NOT_YET_RECRUITING

Does Abatacept Induce Regulatory B Cells in Patients With Rheumatoid Arthritis

NCT02885818 ·Status: COMPLETED

Januse Kinase Inhibition With Filgotinib to Silence Autoreactive B Cells in Rheumatoid Arthritis

NCT05502731 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4